NEXIEN BIOPHARMA INC earned $0.00 per diluted share in fiscal year 2024. This represents an increase of 100.0% from the prior fiscal year. Over the trailing 12 months, Q4 FY2024 through Q3 FY2025, the same line adds up to $0.00 per diluted share. The table below carries 11 fiscal years, from 2014 to 2024, and the quarters NEXIEN BIOPHARMA INC has filed alongside them.
FY2024 annual
EPS (Diluted)$0.00
YoY+100.0%
Source SEC Filings (10-K/10-Q)Latest period Q3 FY2025, ended Mar 31, 2025ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
NXEN EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was NEXIEN BIOPHARMA INC's diluted earnings per share in fiscal year 2024?
NEXIEN BIOPHARMA INC earned $0.00 per diluted share in fiscal year 2024.
How fast is NEXIEN BIOPHARMA INC's diluted earnings per share growing?
NEXIEN BIOPHARMA INC (NXEN) diluted earnings per share rose by 100.0% year over year, from -$0.01 to $0.00 in fiscal year 2024.
What is NEXIEN BIOPHARMA INC's diluted earnings per share over the last twelve months?
NEXIEN BIOPHARMA INC (NXEN) reported $0.00 per diluted share over the trailing 12 months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.
What was NEXIEN BIOPHARMA INC's diluted earnings per share in the most recent quarter?
NEXIEN BIOPHARMA INC (NXEN) reported $0.00 in diluted earnings per share in Q3 2025. This represents a decrease of 100.0% from the same quarter a year earlier.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what NEXIEN BIOPHARMA INC (NXEN) reported on that line in every period on record.
